Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 52, 2023 - Issue 1
142
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Development of a Novel IgG1 Anaphylaxis Mouse Model with Uniquely Characteristic Skin Manifestations Induced Through the FcγRIII-Histamine Pathway

, &

References

  • Balbino B, Herviou P, Godon O, Stackowicz J, Goff OR, Iannascoli B, Sterlin D, Brûlé S, Millot GA, Harris FM, et al. 2020. The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors. J Clin Invest. 130(3):1330–35. doi:10.1172/JCI129697.
  • Benedé S, Berin MC, Fiebiger E. 2018. Mast cell heterogeneity underlies different manifestations of food allergy in mice. PLos One. 13(1):e0190453. doi:10.1371/journal.pone.0190453.
  • Beutier H, Gillis CM, Iannascoli B, Godon O, England P, Sibilano R, Reber LL, Galli SJ, Cragg MS, Van Rooijen N, et al. 2017. IgG subclasses determine pathways of anaphylaxis in mice. J Allergy Clin Immunol. 139(1):269–80.e7. doi:10.1016/j.jaci.2016.03.028.
  • Commins SP. 2017. Outpatient emergencies: anaphylaxis. Med Clin North Am. 101(3):521–36. doi:10.1016/j.mcna.2016.12.003.
  • Dispenza MC, Krier-Burris RA, Chhiba KD, Undem BJ, Robida PA, Bochner BS. 2020. Bruton’s tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis. J Clin Invest. 130(9):4759–70. doi:10.1172/JCI138448.
  • Dunford PJ, Williams KN, Desai PJ, Karlsson L, McQueen D, Thurmond RL. 2007. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol. 119(1):176–83. doi:10.1016/j.jaci.2006.08.034.
  • Dvorak AM, Massey M, Warner J, Kissell S, Kagey-Sobotka A, Lichtenstein LM. 1991. IgE-mediated anaphylactic degranulation of isolated human skin mast cells. Blood. 77(3):569–78. doi:10.1182/blood.V77.3.569.569.
  • Finkelman FD. 2007. Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol. 120(3):506–15. doi:10.1016/j.jaci.2007.07.033.
  • Finkelman FD, Khodoun MV, Strait R. 2016. Human IgE-independent systemic anaphylaxis. J Allergy Clin Immunol. 137(6):1674–80. doi:10.1016/j.jaci.2016.02.015.
  • Hazenbos WL, Gessner JE, Hofhuis FM, Kuipers H, Meyer D, Heijnen IA, Schmidt RE, Sandor M, Capel PJ, Daëron M, et al. 1996. Impaired IgG-dependent anaphylaxis and Arthus reaction in fcγriii (cd16) deficient mice. Immunity. 5(2):181–88. doi:10.1016/s1074-7613(00)80494-x.
  • Hazenbos WL, Heijnen IA, Meyer D, Hofhuis FM, de Lavalette CR, Schmidt RE, Capel PJ, van de Winkel JG, Gessner JE, van den Berg TK, et al. 1998. Murine IgG1 complexes trigger immune effector functions predominantly via FcγRIII (CD16. J Immunol. 161(6):3026–32.
  • He S, Zhang H, Zeng X, Chen D, Yang P. 2013. Mast cells and basophils are essential for allergies: mechanisms of allergic inflammation and a proposed procedure for diagnosis. Acta Pharmacol Sin. 34(10):1270–83. doi:10.1038/aps.2013.88.
  • Hirayama N, Hirano T, Köhler G, Kurata A, Okumura K, Ovary Z. 1982. Biological activities of antitrinitrophenyl and antidinitrophenyl mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 79(2):613–15.
  • Jiao D, Liu Y, Lu X, Liu B, Pan Q, Liu Y, Liu Y, Zhu P, Fu N. 2014. Macrophages are the dominant effector cells responsible for IgG-mediated passive systemic anaphylaxis challenged by natural protein antigen in BALB/c and C57BL/6 mice. Cell Immunol. 289(1–2):97–105. doi:10.1016/j.cellimm.2014.03.018.
  • Jönsson F, de Chaisemartin L, Granger V, Gouel-Chéron A, Gillis CM, Zhu Q, Dib F, Nicaise-Roland P, Ganneau C, Hurtado-Nedelec M, et al. 2019. An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis. Sci Transl Med. 11(500):eaat1479. doi:10.1126/scitranslmed.aat1479.
  • Jönsson F, Mancardi DA, Kita Y, Karasuyama H, Iannascoli B, Rooijen NV, Shimizu T, Daëron M, Bruhns P. 2011. Mouse and human neutrophils induce anaphylaxis. J Clin Invest. 121(4):1484–96. doi:10.1172/JCI45232.
  • Khodoun MV, Kucuk ZY, Strait RT, Krishnamurthy D, Janek K, Clay CD, Morris SC, Finkelman FD. 2013. Rapid desensitization of mice with anti-FcγRIIb/FcγRIII mAb safely prevents IgG-mediated anaphylaxis. J Allergy Clin Immunol. 132(6):1375–87.
  • Khodoun MV, Strait R, Armstrong L, Yanase N, Finkelman FD. 2011. Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis. Proc Natl Acad Sci U S A. 108(30):12413–18. doi:10.1073/pnas.1105695108.
  • Kimura S, Nagata M, Takeuchi M, Takano K, Harada M. 1997. Anti-granulocyte antibody suppression of active and passive anaphylactic shock in WBB6F1-W/Wv mice. Cell Mol Life Sci. 53(8):663–66. doi:10.1007/s000180050085.
  • Klos A, Tenner AJ, Johswich K-O, Ager RR, Reis ES, Köhl J. 2009. The role of the anaphylatoxins in health and disease. Mol Immunol. 46(14):2753–66. doi:10.1016/j.molimm.2009.04.027.
  • Lakin J, Blocker T, Strong DM, Yocum M. 1978. Anaphylaxis to protamine sulfate mediated by complement-dependent IgG antibody. J Allergy Clin Immunol. 61(2):102–07. doi:10.1016/0091-6749(78)90232-4.
  • Lieberman P, Garvey LH. 2016. Mast cells and anaphylaxis. Curr Allergy Asthma Rep. 16(3):20. doi:10.1007/s11882-016-0598-5.
  • LoVerde D, Iweala OI, Eginli A, Krishnaswamy G. 2018. Anaphylaxis. Chest. 153:528–43. doi:10.1016/j.chest.2017.07.033.
  • Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP, Galli SJ. 1997. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J Clin Invest. 99(5):901–14. doi:10.1016/j.jaci.2013.09.008.
  • Mukai K, Obata K, Tsujimura Y, Karasuyama H. 2009. New insights into the roles for basophils in acute and chronic allergy. Allergol Int. 58(1):11–19. doi:10.2332/allergolint.08-RAI-0059.
  • Nakamura T, Fukaya T, Uto T, Takagi H, Arimura K, Tono T, Sato K. 2017. Selective depletion of basophils ameliorates immunoglobulin E-mediated anaphylaxis. Biochem Biophys Rep. 9:29–35. doi:10.1016/j.bbrep.2016.11.001.
  • Oka T, Kalesnikoff J, Starkl P, Tsai M, Galli S. 2012. Evidence questioning cromolyn’s effectiveness and selectivity as a ‘mast cell stabilizer’ in mice. Lab Invest. 92(10):1472–82. doi:10.1038/labinvest.2012.116.
  • Pellefigues C, Mehta P, Chappell S, Yumnam B, Old S, Camberis M, Le Gros G. 2021. Diverse innate stimuli activate basophils through pathways involving Syk and IκB kinases. Proc Natl Acad Sci USA. 118(12):e2019524118. doi:10.1073/pnas.2019524118.
  • Pellefigues C, Mehta P, Prout MS, Naidoo K, Yumnam B, Chandler J, Chappell S, Filbey K, Camberis M, Le Gros G. 2019. the Basoph8 mice enable an unbiased detection and a conditional depletion of basophils. Front Immunol. 10:2143. doi:10.3389/fimmu.2019.02143.
  • Reber LL, Hernandez JD, Galli SJ. 2017. The pathophysiology of anaphylaxis. J Allergy Clin Immunol. 140(2):335–48. doi:10.1016/j.jaci.2017.06.003.
  • Schäfer B, Piliponsky AM, Oka T, Song CH, Gerard NP, Gerard C, Tsai M, Kalesnikoff J, Galli SJ. 2013. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. J Allergy Clin Immunol. 131(2):541–8.e9. doi:10.1016/j.jaci.2012.05.009.
  • Shimada SG, LaMotte RH. 2008. Behavioral differentiation between itch and pain in mouse. Pain. 139:681–87. doi:10.1016/j.pain.2008.08.002.
  • Singer E, Zodda D, Moellman J, Silverburg M. 2015. Allergy and anaphylaxis: principles of acute emergency management. Emerg Med Pract. 17:1–24.
  • Sokol CL, Barton GM, Farr AG, Medzhitov R. 2018. A mechanism for the initiation of the Th2 response by an allergen. Nat Immunol. 9:310–18. doi:10.1038/ni1558.
  • Strait RT, Morris SC, Yang M, Qu X-W, Finkelman FD. 2002. Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol. 109(4):658–68. doi:10.1067/mai.2002.123302.
  • Suzuki O, Koura M, Noguchi Y, Uchio-Yamada K, Matsuda J. 2013. Zygosity Determination in Hairless Mice by PCR Based on Hrhr Gene Analysis. Exp Anim. 62(3):267–73. doi:10.1538/expanim.62.267.
  • Tsujimura Y, Obata K, Mukai K, Shindou H, Yoshida M, Nishikado H, Kawano Y, Minegishi Y, Shimizu T, Karasuyama H. 2008. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity. 28(4):581–89. doi:10.1016/j.immuni.2008.02.008.
  • Wada T, Ishiwata K, Koseki H, Ishikura T, Ugajin T, Ohnuma N, Obata K, Ishikawa R, Yoshikawa S, Mukai K, et al. 2010. Selective ablation of basophils in mice reveals their nonredundant role in acquired immunity against ticks. J Clin Invest. 120(8):2867–75. doi:10.1172/JCI42680.
  • Warrington R, Watson W, Kim HL, Antonetti FR. 2011. Introduction to immunology and immunopathology. Allergy Asthma Clin Immunol. 7(S1):S1. doi:10.1186/1710-1492-7-S1-S1.
  • Xing W, Austen KF, Gurish MF, Jones TG. 2011. Protease phenotype of constitutive connective tissue and of induced mucosal mast cells in mice is regulated by the tissue. Proc Natl Acad Sci U S A. 108(34):14210–15. doi:10.1073/pnas.1111048108.
  • Yamaki K, Miyatake K, Nakashima T, Morioka A, Yamamoto M, Ishibashi Y, Ito A, Kuranishi A, Yoshino S. 2014. Intravenous IgA complexed with antigen reduces primary antibody response to the antigen and anaphylaxis upon antigen re-exposure by inhibiting Th1 and Th2 activation in mice. Immunopharmacol Immunotoxicol. 36(5):316–28. doi:10.3109/08923973.2014.946143.
  • Yamaki K, Yoshino S. 2015. Establishment of a mouse anti-ovalbumin IgE monoclonal antibody that induces FcɛRII (CD23)-dependent activation without FcɛRI-dependent activation. Monoclon Antib Immunodiagn Immunother. 34(6):423–31. doi:10.1089/mab.2015.0032.
  • Yamaki K, Yoshino S. 2016. A new, rapid in vivo method to evaluate allergic responses through distinctive distribution of a fluorescent-labeled immune complex: potential to investigate anti-allergic effects of compounds administered either systemically or topically to the skin. J Immunol Methods. 428:58–68. doi:10.1016/j.jim.2015.11.010.
  • Yu RJ, Krantz MS, Phillips EJ, Stone CA. 2020. Emerging causes of drug-induced anaphylaxis: a review of anaphylaxis-associated reports in the FDA adverse event reporting system (FAERS). J Allergy Clin Immunol. 9(2):819–29.e2. doi:10.1016/j.jaip.2020.09.021.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.